Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441545
Status:
COMPLETED
Last Update Posted:
2021-06-11
First Post:
2007-02-27
Brief Title:
Head to Head Study Against Sevelamer Hydrochloride
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
A Prospective Multicenter Open-label Randomized Cross-over Study to Compare the Efficacy and Safety of Fosrenol and Sevelamer Hydrochloride in Patients Receiving Hemodialysis for End Stage Renal Disease
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the efficacy of Fosrenol Lanthanum carbonate and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline
Detailed Description:
To compare the efficacy of Fosrenol Lanthanum carbonate and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-004959-38 | EUDRACT_NUMBER | None | None |